There were 445 press releases posted in the last 24 hours and 403,304 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Inventiva announces completion of enrollment in the Phase 3 NATiV3 clinical trial of lanifibranor in patients with MASH and advanced fibrosis

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.